[HTML][HTML] Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer
L Zubiri, GE Molina, MJ Mooradian… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Background In 2017, Massachusetts General Hospital implemented the Severe
Immunotherapy Complications (SIC) Service, a multidisciplinary care team for patients …
Immunotherapy Complications (SIC) Service, a multidisciplinary care team for patients …
Correction: Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for …
L Zubiri, GE Molina, MJ Mooradian - J Immunother, 2021 - ncbi.nlm.nih.gov
Correction: Effect of a multidisciplinary Severe Immunotherapy Complications Service on
outcomes for patients receiving immune checkpoint inhibitor therapy for cancer - PMC Back to …
outcomes for patients receiving immune checkpoint inhibitor therapy for cancer - PMC Back to …
[HTML][HTML] Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer
L Zubiri, GE Molina, MJ Mooradian, J Cohen… - … for ImmunoTherapy of …, 2021 - jitc.bmj.com
Background In 2017, Massachusetts General Hospital implemented the Severe
Immunotherapy Complications (SIC) Service, a multidisciplinary care team for patients …
Immunotherapy Complications (SIC) Service, a multidisciplinary care team for patients …
Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer
L Zubiri, GE Molina, MJ Mooradian… - Journal for …, 2021 - pubmed.ncbi.nlm.nih.gov
Background In 2017, Massachusetts General Hospital implemented the Severe
Immunotherapy Complications (SIC) Service, a multidisciplinary care team for patients …
Immunotherapy Complications (SIC) Service, a multidisciplinary care team for patients …
Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer.
L Zubiri, GE Molina, MJ Mooradian… - … for Immunotherapy of …, 2021 - europepmc.org
Background In 2017, Massachusetts General Hospital implemented the Severe
Immunotherapy Complications (SIC) Service, a multidisciplinary care team for patients …
Immunotherapy Complications (SIC) Service, a multidisciplinary care team for patients …
Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer
L Zubiri, GE Molina, MJ Mooradian… - Journal for …, 2021 - ohsu.elsevierpure.com
Background In 2017, Massachusetts General Hospital implemented the Severe
Immunotherapy Complications (SIC) Service, a multidisciplinary care team for patients …
Immunotherapy Complications (SIC) Service, a multidisciplinary care team for patients …
Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer
L Zubiri, GE Molina, MJ Mooradian… - Journal for …, 2021 - search.proquest.com
Background In 2017, Massachusetts General Hospital implemented the Severe
Immunotherapy Complications (SIC) Service, a multidisciplinary care team for patients …
Immunotherapy Complications (SIC) Service, a multidisciplinary care team for patients …
[引用][C] Correction: Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy …
L Zubiri, GE Molina, MJ Mooradian - J Immunother, 2021 - search.proquest.com
Correction: Effect of a multidisciplinary Severe Immunotherapy Complications Service on
outcomes for patients receiving immune c Page 1 1 J Immunother Cancer 2021;9:e002886corr1 …
outcomes for patients receiving immune c Page 1 1 J Immunother Cancer 2021;9:e002886corr1 …
[引用][C] Correction: Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy …
L Zubiri, GE Molina, MJ Mooradian - J Immunother, 2021 - jitc.bmj.com
Open access This is an open access article distributed in accordance with the Creative
Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to …
Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to …